The effectiveness of erysipelas prophylaxis depends on the cumulative dose of benzathine penicillin G [PDF]
Background: Erysipelas is an acute infection due to S. pyogenes and is characterized by a high risk of relapses. The number of patients suffering from one or more recurrences varied depending on the study and accounted for between 16% and 47% of the ...
Agnieszka Bednarska +8 more
doaj +2 more sources
Quality of benzathine penicillin G: A multinational cross‐sectional study [PDF]
Benzathine penicillin G (BPG) is used as first‐line treatment for most forms of syphilis and as secondary prophylaxis against rheumatic heart disease (RHD).
Robert M. Hand +12 more
doaj +2 more sources
Availability of benzathine penicillin G for syphilis treatment in Shandong Province, Eastern China [PDF]
Background The shortage of benzathine penicillin G (BPG) worldwide presents a major challenge in the treatment of syphilis. Its availability for syphilis treatment has not been adequately evaluated in China.
Xinlong Chen +4 more
doaj +2 more sources
Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease [PDF]
A 7-year old boy developed myositis secondary to intramuscular injection of benzathine penicillin-G in the context of secondary prophylaxis for rheumatic heart disease.
Joshua R. Francis +4 more
doaj +2 more sources
Benzathine Penicillin G Shortage and Secondary Syphilis. [PDF]
Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. This disease is characterized by four different stages, each presenting with a variety of manifestations or asymptomatic disease. These stages can be further broken down into early-stage syphilis, which includes primary and secondary syphilis, and late-stage ...
Snider W, Depew I, Cook S, Roth D.
europepmc +3 more sources
Treatment of Syphilis in Pregnancy and Congenital Syphilis: Current Evidence, Challenges, and Future Directions [PDF]
Syphilis remains a global public health concern, with maternal infection posing a substantial risk for congenital syphilis, a preventable condition associated with severe morbidity and mortality.
Serena Salomè, Chryssoula Tzialla
doaj +2 more sources
Fatal and Near-Fatal Non-allergic Reactions in Patients with Underlying Cardiac Disease Receiving Benzathine Penicillin G in Israel and Switzerland [PDF]
Benzathine Penicillin G (BPG) is commonly used for treatment of penicillin-susceptible infections and secondary prevention of rheumatic fever. Death following administration of BPG is extremely rare—only a handful of cases have been described in the ...
Matitiahu Berkovitch +15 more
doaj +2 more sources
Barriers and facilitators of benzathine penicillin G adherence among rheumatic heart disease patients: a mixed methods systematic review using the COM-B (capability, opportunity, and motivation for behavior) model [PDF]
Background Benzathine penicillin G (BPG) is a proven preventive agent for preventing the progression of rheumatic heart disease (RHD) and is recognized as a standard of care. However, ensuring adherence to BPG remains a global challenge. The objective of
Habtamu Abera Areri +2 more
doaj +2 more sources
Severe adverse reactions to benzathine penicillin G in rheumatic heart disease: A systematic review and meta-analysis. [PDF]
BackgroundFear of severe adverse reaction (SAR) and reluctance of health care providers to administer intramuscular injections are major contributing factors to poor adherence of benzathine penicillin G (BPG) in the management of rheumatic heart disease (
Eshetie Melese Birru +4 more
doaj +2 more sources

